000			01658nam a22001937a 4500
005			20231025132453.0
008			231025b ph ||||| |||| 00| 0 eng d
022			_a0360-4039
040			_cOCT
100			_aGrimmond, Terry
240			_aNursing 2023 _hJuly 2023
245			_aSharps injuries with Lovenox and generic enoxaparin prefilled safety syringers: _bA 12-year retrospective cross-sectional analytical study _cTerry Grimmond, MaryAnn Gruden, Bobbi Jo Hurst, and Lydia F. Crutchfield
260			_aHangerstown, MD _bWolters kluwer Health _c2023
300			_avo. 53 (7) ;pages53-60
505			_aAbstract: Purpose: Investigate the incidence and mechanisms of sharps injuries (SI) to staff using Lovenox and generic enoxaparin prefilled syringers. Methods: Four national adverse event databases were examined over a 12-year period for incidence and brands involved with injury events to staff using enoxaparin prefilled syringers. Results: The search revealed 581 adverse events (including 20 sharps injuries) associated with device malfunction in 8 of 16 brands, with one brand mentioned significantly more frequently than others. No national alert had been issued. Conclusion: Use of certain brands of enoxaparin prefilled syringers poses a small but serious risk of injury to staff. Conducting root cause analyses on all SI is essential, as is the need for regularly evaluating safer devices, reporting all device incidents, enabling simpler reporting of adverse events, and establishing more effective intervention by FDA and manufacturers.
650			_aEnoxaparin, lovenox, malfunction
700			_aGrimmond, Terry
942			_2ddc _cCR _n0
999			_c9260 _d9260